Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP) – a life-threatening fungal infection primarily affecting children and immunocompromised patients – more quickly and less invasively, according to a new study published in the Journal of Clinical Investigation.